By 1978, VPA was approved by the US Food and Drug Administration for treating petit mal (absence) seizures
Athletes & Active Individuals Accelerate muscle recovery, reduce soreness, and restore electrolyte balance after intense workouts
By acting as a co-agonist for both the GLP-1 receptor agonist and amylin pathways, amycretin aims to provide even greater weight reduction than medications that only target GLP-1
Functional testing offers a systems biology lens that helps clinicians uncover hidden triggers, assess downstream consequences, and build more precise therapeutic strategies
These symptoms are linked to how the medication slows digestion, as seen with other GLP-1s
Meanwhile, axonal mitochondria have a remarkably standard small size, taking less than 10% of axonal volume [49, 50]